Ultimovacs ASA (CHIX:ULTIO) Days Payable : 369.92 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Ultimovacs ASA Days Payable?

Ultimovacs ASA's average Accounts Payable for the three months ended in Mar. 2024 was kr12.00 Mil. Ultimovacs ASA's Cost of Goods Sold for the three months ended in Mar. 2024 was kr2.96 Mil. Hence, Ultimovacs ASA's Days Payable for the three months ended in Mar. 2024 was 369.92.

The historical rank and industry rank for Ultimovacs ASA's Days Payable or its related term are showing as below:

CHIX:ULTIo' s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 960.77
Current: 960.77

During the past 9 years, Ultimovacs ASA's highest Days Payable was 960.77. The lowest was 0.00. And the median was 0.00.

CHIX:ULTIo's Days Payable is ranked better than
84.47% of 721 companies
in the Biotechnology industry
Industry Median: 148.28 vs CHIX:ULTIo: 960.77

Ultimovacs ASA's Days Payable declined from Mar. 2023 (1,034.46) to Mar. 2024 (369.92). It may suggest that Ultimovacs ASA accelerated paying its suppliers.

Ultimovacs ASA Days Payable Historical Data

The historical data trend for Ultimovacs ASA's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultimovacs ASA Days Payable Chart

Ultimovacs ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Ultimovacs ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															1,034.46	1,878.09	770.16	-	369.92

Competitive Comparison of Ultimovacs ASA's Days Payable

For the Biotechnology subindustry, Ultimovacs ASA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ultimovacs ASA's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ultimovacs ASA's Days Payable distribution charts can be found below:

* The bar in red indicates where Ultimovacs ASA's Days Payable falls into.

Ultimovacs ASA Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ultimovacs ASA's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (7.655	+	11.169)	/	2 )	/	0	*	365
=	9.412					/	0	*	365
=	N/A

Ultimovacs ASA's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (11.169	+	12.822)	/	2 )	/	2.959	*	365 / 4
=	11.9955					/	2.959	*	365 / 4
=	369.92

Ultimovacs ASA Days Payable Related Terms

Thank you for viewing the detailed overview of Ultimovacs ASA's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ultimovacs ASA (CHIX:ULTIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (CHIX:ULTIo) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ULTIo:Sweden ULTI:Norway 7UM:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.ultimovacs.com

Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Ultimovacs ASA (CHIX:ULTIO) Headlines

No Headlines